BioNTech SE (BNTX)
108.23
+6.09
(+5.96%)
USD |
NASDAQ |
Nov 21, 16:00
107.72
-0.51
(-0.47%)
After-Hours: 07:23
BioNTech Shareholders Equity (Quarterly): 21.35B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.35B |
| June 30, 2024 | 20.44B |
| March 31, 2024 | 21.56B |
| December 31, 2023 | 22.38B |
| September 30, 2023 | 21.03B |
| June 30, 2023 | 21.63B |
| March 31, 2023 | 22.10B |
| December 31, 2022 | 21.51B |
| September 30, 2022 | 18.05B |
| June 30, 2022 | 17.58B |
| March 31, 2022 | 17.76B |
| December 31, 2021 | 13.47B |
| Date | Value |
|---|---|
| September 30, 2021 | 10.10B |
| June 30, 2021 | 6.525B |
| March 31, 2021 | 2.954B |
| December 31, 2020 | 1.687B |
| September 30, 2020 | 1.089B |
| June 30, 2020 | 676.98M |
| March 31, 2020 | 494.26M |
| December 31, 2019 | 552.79M |
| September 30, 2019 | 455.59M |
| June 30, 2019 | 437.17M |
| December 31, 2018 | 304.45M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
494.26M
Minimum
Mar 2020
22.38B
Maximum
Dec 2023
13.15B
Average
17.67B
Median
Shareholders Equity (Quarterly) Benchmarks
| Novavax Inc | -526.44M |
| DBV Technologies SA | 54.03M |
| Akari Therapeutics PLC | -6.694M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| NuCana PLC | 4.806M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.02B |
| Total Liabilities (Quarterly) | 3.671B |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 7.328 |
| Net Debt Paydown Yield | -0.03% |